
Stem cell donors are getting younger and better, with mismatched unrelated donors showing promising survival rates for adults…

Discover the hurdles of clinical trial joining and how to overcome them with ease and success in medical…

FDA approves Rasonque, a first-in-class therapy for metastatic pancreatic cancer. Learn about this new targeted treatment.

Husband Kicked From Hospice for Dying Too Slowly: A story of unfair treatment and family struggle as a…

FDA approves Rasonque, a first-in-class therapy for metastatic pancreatic cancer. Learn about this new targeted treatment.

Most people considering facial rejuvenation describe the same vague feeling: something looks different, but they cannot say exactly…

Stem cell donors are getting younger and better, with mismatched unrelated donors showing promising survival rates for adults…

A new study reveals how sensitive caregiving in infancy may reduce ADHD risk linked to prenatal inflammation, offering…

Discover why dermatologists are shifting toward anti-inflammatory seborrheic dermatitis treatment to improve patient outcomes and reduce drug resistance.

The FDA approves Pasatru, a breakthrough drug for fibrodysplasia ossificans progressiva (FOP), a rare bone disease affecting 900…

Sparsentan access guidance for kidney disease patients with evidence-based coverage criteria and clinical judgment.

Researchers find hormone GDF15 triggers a brain‑to‑liver pathway that cuts liver inflammation and fibrosis, offering therapy even without…

Discover the hurdles of clinical trial joining and how to overcome them with ease and success in medical…

California’s generic insulin program, CalRx, offers affordable insulin at $55 but faces slow adoption despite lower costs. Learn…